Drummond WHUse of cardiotonic therapy in the management of infants with PPHN. Clin Perinatol1984 ; 11:715-28.
2.
Symposium on Neonatal Pulmonary Hypertension. In: Philips III JB, ed., Clinics in Perinatology, Phildelphia: W.B. Saunders, 1984 .
3.
Friedman WFThe intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis1972;15:87-9.
4.
Salsburey DJ , Brown DREffects of parenteral calcium treatment on blood pressure and heart rate in neonatal hypocalcemia. Pediatrics1982;69:605—9.
5.
Benitz WE, Malachowski N., Cohen RS, et al. Use of sodium nitroprusside in neonates: efficacy and safety . J Pediatr1985;106:102-10.
6.
Ackerman NB Jr, Delemos RAHigh-frequency ventilation. In: Barnes LA , ed. Advances in Pediatrics, Year Book Medical Publishers, 1984; 259-93.
7.
Bartlett RH, Roloff DW, Cornell RG, et al. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics1985;76:479-87.
8.
Yabek SMNeonatal cyanosis: Reappraisal of response to 100% oxygen breathing. Am J Dis Child1984;138:880-4.
9.
Shannon DC, Lusser M., Goldblatt A., et al. The cyanotic infant: heart disease or lung disease? N Engl J Med1972;287:951-4.
10.
Rao PS, Marino BL, Robertson AF III. Usefulness of continuous positive airway pressure in differential diagnosis of cardiac from pulmonary cyanosis in newborn infants. Arch Dis Child1978;53:456-60.
11.
Fox WW, Duara S.Persistent pulmonary hypertension in the neonate: Diagnosis and management . J Pediatr1983;103:505-14.
12.
Bruce DAEffects of hyperventilation on cerebral blood flow and metabolism. Clin Perinatol1984;11:673-80.
13.
Heymann MAPharmacologic use of prostaglandin E1 in infants with congenital heart disease. Am Heart J1981;101:837-43.
14.
Rojas J., Stahlman M.The effects of Group B streptococcus and other organisms on the pulmonary vasculature. Clin Perinatol1984;11:591-9.